Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Calithera Biosciences stock opened at $0.01 on Friday. The company has a fifty day simple moving average of $0.01 and a 200-day simple moving average of $0.01. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.